Clinical Trials in Los Angeles

Showing 2861-2880 of 14,465 trials

Value-based Integrated Recommendation Software Guiding Ovarian Cancer Treatment (VIRGO2)

NCT05523700

This study will evaluate the use of a mobile application in improving the patient-reported health outcome measures (PROMIS) for patients diagnosed with advanced stage ovarian, fallopian tube, and primary peritoneal cancer. The application will incorporate clinical data from the patient's medical chart as well as capture patient-reported outcome measures on an ongoing basis to better inform physicians and the care team so that necessary interventions may be implemented.

Ovarian Cancer

Jonsson Comprehensive Cancer Center10 participantsStarted Oct 2023

Los Angeles, California, United States

COMPLETEDPhase 2< 1 mile

A Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of SPR720 as Compared With Placebo for the Treatment of Participants With Mycobacterium Avium Complex (MAC) Pulmonary Disease

NCT05496374

The purpose of the study is to evaluate 1. The microbiological response and clinical efficacy of SPR720 compared with placebo in participants with nontuberculous mycobacteria pulmonary disease (NTM-PD). 2. The safety and tolerability of SPR720 in participants with NTM- PD 3. The pharmacokinetic (PK) of SPR719, active moiety, following orally (po) administered prodrug SPR720 in participants with NTM-PD.

Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD)

Spero Therapeutics25 participantsStarted Dec 2022

Birmingham, Alabama, United States • Fresno, California, United States • Los Angeles, California, United States +25 more locations

Value-based Integrated Recommendation Software Guiding Ovarian Cancer Treatment (VIRGO2)

A Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of SPR720 as Compared With Placebo for the Treatment of Participants With Mycobacterium Avium Complex (MAC) Pulmonary Disease

Find Trials by Condition in Los Angeles

A Study of DKN-01 in Combination With Tislelizumab ± Chemotherapy in Patients With Gastric or Gastroesophageal Cancer

Aviptadil for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial)

Clinical Performance of Two Frequent Replacement Silicone Hydrogel Multifocal Contact Lenses

Digital Inhaler Use in Obstructive Lung Disease Care

Safety, Tolerability and Efficacy Study of ARCT-032 in People With Cystic Fibrosis

Dose Ranging Study of Amlitelimab in Adult Participants With Moderate-to-severe Asthma

Safety Study of Zinc Finger Nuclease CCR5-modified Hematopoietic Stem/Progenitor Cells in HIV-1 Infected Patients

A Dose-ranging Study in Patients With Diabetic Peripheral Neuropathic Pain (DPNP)

Extension of Phase 3 Gene Therapy for Painful Diabetic Neuropathy

MiRisten for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia

NEURESCUE Device as an Adjunct to In-Hospital Cardiac Arrest (ARISE)

ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic Valve Implantation

Natural History of Netherton Syndrome

Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung Cancer

A Study to Assess the Safety, Tolerability, and Effect on Disease Progression of BIIB105 in Participants With Amyotrophic Lateral Sclerosis (ALS) and Participants With the ALS Ataxin-2 (ATXN2) Genetic Mutation

The Periviable GOALS Decision Support Tool

A Study of Safety and Efficacy of Tildacerfont in Females With Polycystic Ovary Syndrome and Elevated Adrenal Androgens

A Phase 2 Multicenter Study of High Dose Chemotherapy With Autologous Stem Cell Transplant Followed by Maintenance Therapy With Romidepsin for the Treatment of T Cell Non-Hodgkin Lymphoma